Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The effects of vildagliptin in addition to insulin on glycaemic control in haemodialysis patients with type 2 diabetes mellitus

Trial Profile

The effects of vildagliptin in addition to insulin on glycaemic control in haemodialysis patients with type 2 diabetes mellitus

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 24 Nov 2014

At a glance

  • Drugs Vildagliptin (Primary) ; Insulin
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 13 Dec 2013 Planned End Date (13 May 2014) added as reported by University Hospital Medical Information Network - Japan.
    • 13 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 14 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top